
CAS 1644279-16-2: 4,10-bis(4-bromobenzoyl)-6,11-dihydro-Indolo[3,2-c][1]benzazepin-12(5H)-one
Description:4,10-bis(4-bromobenzoyl)-6,11-dihydro-Indolo[3,2-c][1]benzazepin-12(5H)-one is a complex organic compound characterized by its unique indolo-benzazepine structure, which incorporates multiple aromatic rings and functional groups. The presence of bromine atoms in the 4-bromobenzoyl substituents contributes to its potential reactivity and biological activity, as brominated compounds often exhibit enhanced pharmacological properties. This compound is likely to be a solid at room temperature, with a specific melting point and solubility characteristics that depend on the solvent used. Its molecular structure suggests potential applications in medicinal chemistry, particularly in the development of pharmaceuticals targeting various biological pathways. The compound's synthesis may involve multi-step organic reactions, including bromination and acylation processes. Additionally, its stability, reactivity, and interaction with biological systems would be of interest for further research, particularly in the context of drug design and development. As with many complex organic molecules, safety and handling precautions are essential due to potential toxicity or reactivity.
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
![]() | Bromfenac Impurity 28 REF: 4Z-B-4735CAS: 1644279-16-2 | - - - | To inquire | Tue 25 Mar 25 |
![]() | 6,11-Dihydro-indolo[3,2-c][1]benzazepin-12(5H)-one, 4,10-bis(4-bromobenzoyl) REF: TR-O561160CAS: 1644279-16-2 | - - - | 1,547.00 € | Tue 06 May 25 |

Ref: 4Z-B-4735
5mg | To inquire | ||
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |

6,11-Dihydro-indolo[3,2-c][1]benzazepin-12(5H)-one, 4,10-bis(4-bromobenzoyl)
Controlled ProductRef: TR-O561160
100mg | 1,547.00 € |